Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Scavenger receptor class A member 5 (SCARA5) is a type II transmembrane glycoprotein belonging to the class A scavenger receptor family, which assembles as a cell-surface trimer and contains a collagen-like domain and a scavenger receptor cysteine-rich (SRCR) domain. It acts as an endocytic receptor for ferritin and von Willebrand factor, playing a key role in iron homeostasis, innate immune response, and clearance of plasma proteins. SCARA5 is expressed in various tissues, notably in epithelial cells and some endothelial cells, and functions as a tumor suppressor in several malignancies, where its downregulation is associated with increased proliferation, migration, and metastasis. Mechanistically, SCARA5 regulates cell cycle progression, apoptosis, unfolded protein response, and inhibits oncogenic signaling pathways such as PI3K/AKT. There are no known drugs directly targeting SCARA5, but its role as a tumor suppressor and plasma protein clearance receptor makes it a candidate for biomarker development and future therapeutic targeting.
As a tumor suppressor: SCARA5 overexpression inhibits proliferation and migration, induces apoptosis via inhibition of the PI3K/AKT pathway, and causes cell cycle arrest at G2/M phase. Endocytic receptor: SCARA5 enables uptake and clearance of ferritin and von Willebrand factor from plasma, potentially impacting iron and coagulation homeostasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Scavenger receptor class A member 5 (SCARA5).